PMC9948010_01
(A) An Abdominal computed tomographic scan and contrast-enhanced scan taken on March 17, 2020, showing a mass in the head of the pancreas, with atrophy of the body and tail of the pancreas, and the pancreatic duct obviously dilated. (B) Magnetic Resonance Cholangiopancreatography imaging examination taken on March 19, 2020, showing a space-occupying lesion in the head of the pancreas, with obvious dilation of the pancreatic duct at the tail of the pancreas.
fonc-13-1091635-g001.jpg
PMC9948010_01_fonc-13-1091635-g001.jpg
f1
Contrast-enhanced CT scan (Figure 1) revealed a mass in the head of the pancreas, with atrophy of the body and the tail of the pancreas, and the pancreatic duct was dilated, which suggested pancreatic cancer. Magnetic Resonance Cholangiopancreatography (Figure 1) revealed a space-occupying lesion in the head of the pancreas.
(A-C). Microscopic picture with hematoxylin and eosin staining showing the renal cell carcinoma within the pancreatic tissue. (D). Immunohistochemistry staining of the resected lesion from the pancreas, showing positive CK. (E). Immunohistochemistry staining of the resected lesion from the pancreas, showing positive CD10. (F). Immunohistochemistry staining of the resected lesion from the pancreas, showing positive PAX-8.
fonc-13-1091635-g002.jpg
PMC9948010_01_fonc-13-1091635-g002.jpg
f2
The microscopic image examination after hematoxylin and eosin staining (Figures 2A-C) revealed renal cell carcinoma within the pancreatic tissue. Histopathological examination (Figures 2D-F) revealed paired box gene 8-positive (PAX-8+), cluster of differentiation 10-positive (CD10+) and creatine kinase-positive (CK+) cells.
timeline of our patient.
fonc-13-1091635-g003.jpg
PMC9948010_01_fonc-13-1091635-g003.jpg
f3
The timeline of the case is presented in Figure 3.